Drugs to Promote Sinus Rhythm Reversion and Maintenance in Atrial Fibrillation—Why Amiodarone is Better Stanley Nattel Editorial Board Pages: 5 - 6
Exercise Intolerance During Post-MI Heart Failure in Rats: Prevention with Supplemental Dietary Propionyl-L-Carnitine Stanley G. KohDaniel A. BrennerKurt W. Saupe OriginalPaper Pages: 7 - 14
Drugs Modifying Nitric Oxide Metabolism Affect Plasma Cholesterol Levels, Coagulation Parameters, Blood Pressure Values and the Appearance of Plasma Myocardial Necrosis Markers in Rabbits: Opposite Effects of L-NAME and Nitroglycerine Arnaldo PinelliSilvio TrivulzioRoberto Accinni OriginalPaper Pages: 15 - 23
Reduction of Infarct Size by Short-Term Pretreatment with Atorvastatin Yochai BirnbaumTaras AshitkovMassoud Motamedi OriginalPaper Pages: 25 - 30
Effects of Amiodarone and Diltiazem on Persistent Atrial Fibrillation Conversion and Recurrence Rates: A Randomized Controlled Study Emmanuel G. ManiosHercules E. MavrakisPanos E. Vardas OriginalPaper Pages: 31 - 39
Cardiovascular Effects of Natriuretic Peptides and Their Interrelation with Endothelin-1 Bo HanYonathan Hasin ReviewPaper Pages: 41 - 52
HDL-C and Triglyceride Levels: Relationship to Coronary Heart Disease and Treatment with Statins Allan Gaw ReviewPaper Pages: 53 - 62
Angiotensin-Receptor Blockers: Revival of the Systemic Prevention of Restenosis? Robert L. Wilensky ReviewPaper Pages: 63 - 73
Genetic Polymorphisms in Emerging Cardiovascular Risk Factors and Response to Statin Therapy Kimberly A. Dornbrook-LavenderJohn A. Pieper ReviewPaper Pages: 75 - 82
PERTINENT—PERindopril–Thrombosis, InflammatioN, Endothelial Dysfunction and Neurohormonal Activation Trial: A Sub-Study of the EUROPA Study Roberto Ferrari OriginalPaper Pages: 83 - 91
Effect of 17β-Estradiol on Soluble P-Selectin in Coronary Artery Bypass Grafting Minxin WeiJari LaurikkaMatti Tarkka Letter to the Editor Pages: 93 - 94
Low-Dose Flecainide Infusion Followed by Oral Pilsicainide is Highly Effective and Safe for Paroxysmal Atrial Fibrillation Shunichi NagaiYasuchika TakeishiIsao Kubota Letter to the Editor Pages: 95 - 97